Medpace Holdings, Inc. to Present at Jefferies Global Healthcare Conference

CINCINNATI--(BUSINESS WIRE)-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference in June:

Jefferies Global Healthcare ConferenceLocation: New York, NYDate: Tuesday, June 5, 2018Presentation: 11:30 a.m. ETSpeakers: Dr. August Troendle, President & Chief Executive Officer, and Jesse Geiger, Chief Financial Officer & Chief Operating Officer, Laboratory Operations

A live webcast of each presentation will be accessible through the “Investors” section of the Company’s website at www.medpace.com and will be available for replay following each event.

About Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,600 people across 35 countries.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180524006228/en/

Medpace Holdings, Inc.
Media Contact:
Julie Hopkins, 513-579-9911 x12627
[email protected]
or
Investor Contact:
[email protected]

Source: Medpace Holdings, Inc.

You May Also Be Interested In

• Seven Carter Arnett Stahl + Cho Hernandez Attorneys Honored in 2027 Best Lawyers in America Guide
• Purchase of Own Securities and Total Voting Rights
• Sofidel and WWF Italy Renew Their Partnership on Climate and Energy, Responsible Sourcing, and Awareness-Raising Activities